Locations:

Tag: CAR-T cell therapy

June 3, 2024/Cancer/Research

CAR T-Cell Treatment Offers Hope for Richter Transformation

Real-world study shows high response rates that are durable with commercial lisocabtagene maraleucel

April 12, 2024/Rheumatology & Immunology/Immunologic Diseases

The Evolution of CAR T Therapy and Its Use in Systemic Lupus Erythematosus

Advancements lead to a new trial involving autoimmune disease

December 15, 2023/Cancer/Research

CAR T-Cell Therapy Effective in Refractory Double-Hit/Triple-Hit Lymphoma

Two thirds of patients responded to CAR T-cell therapy

April 5, 2023/Cancer/Blood Cancers

Insights About CAR T-Cell Therapy

Dispelling myths and sharing practical experiences

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 9, 2019/Cancer/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

October 16, 2018/Pediatrics/Innovation & Technology

Cleveland Clinic Children’s Certified to Provide First FDA-Approved CAR-T Cell Therapy for Certain Leukemias

A highly innovative treatment process for young people

BackPage 2 of 2Next